Infiniplex
3 known investors
Find your way into Infiniplex
408 people in our graph share verified history with the Infiniplex team — schools, employers, funds. One of them is your warm intro.
Ana Andreescuunlockedknows Zeev Russak · together at HP (overlapped)
×5knows the team · via Bar-Ilan University
×2knows the team · via Technion
×4knows the team · via HP
Infiniplex is a precision oncology company developing InfiniplexDX, a liquid biopsy platform that uses proprietary primer design and molecular-switch chemistry with software-based signal analysis to detect cancer mutations in blood and urine on standard PCR instruments. It targets five clinical indications (bladder cancer, myelodysplastic syndromes, pancreatic, colorectal, and non-small cell lung cancer) to support treatment decisions without tissue biopsies.
Founders & leadership
AS
Alon ShalevinCEO
ZR
Zeev RussakinCTOHe has background in integrating artificial intelligence with molecular biology for healthcare applications.
EH
Efrat HerscovitchCFO
AE
Asa EitanCSO
Investors · 3
In the news
Frequently asked questions
- What does Infiniplex do?
- Infiniplex is a precision oncology company developing InfiniplexDX, a liquid biopsy platform that uses proprietary primer design and molecular-switch chemistry with software-based signal analysis to detect cancer mutations in blood and urine on standard PCR instruments. It targets five clinical indications (bladder cancer, myelodysplastic syndromes, pancreatic, colorectal, and non-small cell lung cancer) to support treatment decisions without tissue biopsies.
- Who are Infiniplex's investors?
- Infiniplex's investors include Bosch Ventures, Robert Bosch Venture Capital, Terra Venture Partners.